Richard Ambinder
Affiliations: | Johns Hopkins University, Baltimore, MD |
Area:
Molecular Biology, Cell Biology, Microbiology BiologyGoogle:
"Richard Ambinder"Children
Sign in to add trainee| Stacy M. Moore | grad student | 2000 | Johns Hopkins |
| Jennifer S. Cannon | grad student | 2001 | Johns Hopkins |
| Yvette C. Tanhehco | grad student | 2005 | Johns Hopkins |
| Jianmeng Chen | grad student | 2007 | Johns Hopkins |
| John J. Strouse | grad student | 2009 | Johns Hopkins |
| Rosalyn A. Juergens | grad student | 2012 | Johns Hopkins |
| Courtney M. Shirley | grad student | 2012 | Johns Hopkins |
| Andrew L. DuFresne | grad student | 2013 | Johns Hopkins |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Li M, Smith BJ, Lee J, et al. (2024) Nelfinavir inhibition of Kaposi's sarcoma-associated herpesvirus protein expression and capsid assembly. Infectious Agents and Cancer. 19: 7 |
| Li M, Smith B, Lee J, et al. (2023) Nelfinavir Inhibition of Kaposi's sarcoma-associated herpesvirus protein expression and capsid assembly. Research Square |
| Lee J, Stone J, Desai P, et al. (2021) Arsenicals, the Integrated Stress Response, and Epstein-Barr Virus Lytic Gene Expression. Viruses. 13 |
| Ambinder RF. (2021) Epstein-Barr Virus-Associated Post-transplant Lymphoproliferative Disease. Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer. 217: 197-207 |
| Lee J, Kosowicz JG, Hayward SD, et al. (2019) Pharmacologic Activation of Lytic Epstein-Barr Virus Gene Expression Without Virion Production. Journal of Virology |
| Keller MD, Darko S, Lang H, et al. (2019) T-cell receptor sequencing demonstrates persistence of virus-specific T cells after antiviral immunotherapy. British Journal of Haematology |
| Ambinder RF. (2018) A viral protein kinase drug target for tumors? The Journal of Clinical Investigation |
| Ramos JC, Sparano JA, Rudek MA, et al. (2018) Safety and Preliminary Efficacy of Vorinostat With R-EPOCH in High-risk HIV-associated Non-Hodgkin's Lymphoma (AMC-075). Clinical Lymphoma, Myeloma & Leukemia |
| Hosseinipour MC, Kang M, Krown SE, et al. (2018) As-Needed versus Immediate Etoposide Chemotherapy in Combination with Antiretroviral Therapy for Mild or Moderate AIDS-associated Kaposi Sarcoma in Resource-Limited Settings: A5264/AMC-067 Randomized Clinical Trial. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America |
| Kosowicz JG, Lee J, Peiffer B, et al. (2017) Drug modulators of B cell signaling pathways and Epstein-Barr virus lytic activation. Journal of Virology |